Pharmaxis Announces ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge … – Sacramento Bee

Pharmaxis Announces ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge
Sacramento Bee
ARIDOL, the only dry powder bronchial challenge test approved for use in the United States, is used to assess bronchial hyperresponsiveness in patients six years of age and older who do not have clinically apparent asthma. ARIDOL should not be used as

and more »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.